Long COVID: Skeptics Are Wrong, Researchers Say
WHRY collaborator Akiko Iwasaki, PhD, joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease. Listen to their discussion as part of "Conversations on Health Care."Source: Community Health Center
Black Women Excluded from Critical Studies Due to ‘Weathering’
Researchers theorize Black women age earlier and faster as a result of being "weathered" by a lifetime of racial discrimination and race-based stressors. As a result, many Black women are excluded from clinical research studies after reaching age-based milestones earlier.
What is it Like to Live with Brain Fog?
Akiko Iwasaki, Yale professor of immunobiology and WHRY collaborator, is the co-author of a review article on Covid-19 related cognitive impairment. The condition has affected people with cancer and other chronic conditions for years, but long Covid is just beginning to push it into the spotlight.Source: Washington Post
Reduce burnout, increase your publishing success, accelerate your next promotion in academic medicine and more from Julie Silver, MD
Reducing burnout, addressing patient care, accelerating your next promotion in academic medicine and more - register for a session with Julie Silver, MD, associate professor and associate chair, Department of Physical Medicine and Rehabilitation, Harvard Medical School, to campus on Thursday, December 1 and Friday, December 2, 2022.
Will Long COVID Research Provide Answers for Poorly Understood Diseases Like ME/CFS?
ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) is a highly disabling, severe condition that has been largely overlooked and even questioned as an illness by physicians and biomedical researchers for decades. But now, scientists including Yale's Akiko Iwasaki and Harlan Krumholz are finding parallels between post-infection long COVID and ME/CFS.
Perceived discrimination increased the risk of worse health outcomes after a heart attack
An analysis of more than 2,600 heart attack survivors, ages 55 years and younger, found that nearly 35% of them reported perceived discrimination in their everyday lives.Source: American Heart Association News
‘Prime and Spike’ Nasal Vaccine Strategy Helps Combat COVID
The new “prime” and “spike” approach may help prevent breakthrough infections of vaccinated individuals by bolstering immune response within the mucosal lining of the respiratory tract, which are the first cells attacked by COVID-19.Source: YaleNews
Atrial Fibrillation Diminishes Women’s Quality of Life and Presents Treatment Complications More Than for Men
A new study revealed several major differences. Men, for instance, tended to experience persistent atrial fibrillation. Women, on the other hand, were mostly paroxysmal, meaning they went in and out of atrial fibrillation and were often more symptomatic.
Women more likely than men to have adverse events after AF ablation
Among patients who had catheter ablation for atrial fibrillation, women were more likely than men to require hospitalization for more than 1 day, to have major adverse events and to have poor quality of life outcomes, researchers reported.Source: Healio
Ensuring Bone Health for Adolescents Identifying as Transgender
With a grant from Women's Health Research at Yale, Dr. Stuart Weinzimer, in collaboration with Drs. Thomas Carpenter and Christy Olezeski, is using sophisticated methods to obtain a picture of the dynamic process of bone development in adolescents undergoing gender-affirming hormone therapy.
Building Momentum: WHRY's Undergraduate Fellows Advance Women's Health
Women’s Health Research at Yale mentors undergraduate students as well as graduate students and rising junior faculty members to ensure that the next generation of scientists and medical providers fully account for the health needs of women and sex-and-gender differences affecting health. Here are a few examples of what our former undergraduate fellows are up to now.
Fighting Breast and Ovarian Cancer With a Lupus Antibody
After discovering a specific lupus antibody that can penetrate cancer cells and, with a grant from Women's Health Research at Yale, showing it makes cancer cells vulnerable to standard treatments, Dr. Peter Glazer and his colleagues are moving a treatment to clinical trials.
Sex Differences in Gastrointestinal Cancer
With this year's Wendy U. and Thomas C. Naratil Pioneer Award and co-funding from the Yale Cancer Center, Dr. Pamela Kunz is conducting one of the first studies to examine sex differences in treating neuroendocrine neoplasms (NENs), a rare form of cancer often found in the gastrointestinal tract.
Is IVL equally effective in male and female patients? Shockwave Medical aims to find out with a historic new study
Shockwave Medical has announced a new clinical trial focused on the safety and effectiveness of its intravascular lithotripsy (IVL) technology in female patients.Source: Cardiovascular Business